InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Liu David R.. Director active across 1 company, notably Prime Medicine, Inc.. Cumulatively, 7 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €140k. Activity tracked since 21 July 2023. The latest transaction was disclosed on 30 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Liu David R. is a declarant linked to Prime Medicine, Inc. on XNAS. He has 7 filings in total, and in the sampled recent filings the period runs from 2022-10-26 to 2025-07-01, with buys of EUR 140153 and no sells; the modal transaction nature is Acquisition.